NewAge, Inc. Announces That Its Common Stock Has Ceased Trading On Nasdaq
$NBEV
Beverages (Production/Distribution)
Consumer Staples
NewAge, Inc. Announces That Its Common Stock Has Ceased Trading On Nasdaq
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/10/2021 | $6.50 → $6.00 | Buy | Roth Capital |
8-K - NewAge, Inc. (0001579823) (Filer)
25-NSE - NewAge, Inc. (0001579823) (Subject)
8-K - NewAge, Inc. (0001579823) (Filer)
3 - NewAge, Inc. (0001579823) (Issuer)
3 - NewAge, Inc. (0001579823) (Issuer)
4 - NewAge, Inc. (0001579823) (Issuer)
SC 13G - NewAge, Inc. (0001579823) (Subject)
SC 13G/A - NewAge, Inc. (0001579823) (Subject)
SALT LAKE CITY, March 15, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), a direct selling company with a primary focus on healthy products, today announced its fourth quarter and full year 2021 earnings release and conference call will be rescheduled to allow additional time to complete its Annual Report on Form 10-K. The Company will be filing a Form 12b-25, Notification of Late Filing, on March 16, 2022, which will provide the Company with a 15-day extension to file its Form 10-K. The Company expects to report financial results for the quarter and full year ended December 31, 2021, on or before March 31, 2022, the expiration date of the extension period. Updated conference call det
SALT LAKE CITY, Feb. 25, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), a direct-to-consumer (D2C) healthy products company, today announced that it will release financial results for its fourth quarter and full year ended December 31, 2021, after the market close on Wednesday, March 16, 2022. A conference call and audio webcast with analysts and investors will be held that afternoon at 5:00 p.m. Eastern Time/3:00 p.m. Mountain Time to discuss the results and answer questions. Live conference call: 1-877-407-3982 (domestic) or 1-201-493-6780 (international) with conference ID: 13727435.Live and archived webcast will be available here and on the Events page of NewAge's investor rela
DENVER, Nov. 09, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, today announced financial results for the third quarter of 2021. Third Quarter 2021 Highlights -Net revenue increased 59% to $100 million compared to $63 million in the third quarter of 2020 -Gross profit was $66 million compared to $37 million in the prior year third quarter, an increase of $29 million -Gross margin reached 66.3% of net revenue compared to 59.8% of revenue in the prior year third quarter, up 6.5 points -Net income improved $11.4 million to ($2.7) million, or ($0.02) per basic share -Adjusted EBITDA1 improved $4.0 million t
SALT LAKE CITY, Sept. 09, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (OTC:NBEVQ) (the "Company"), the Utah-based direct-to-consumer (D2C) organic and healthy products company, today announced that its wholly-owned subsidiaries, NABC, Inc. and NABC Properties, LLC (together, "NABC"), have entered into a definitive agreement to sell the legacy direct store distribution ("DSD") division to Legacy Distribution Group, a Colorado-based distribution company. The transaction is expected to be completed in the fourth quarter of 2022, and closing will be subject to court approval in the Company's pending bankruptcy case. The Company believes the DSD business is one of the largest independent distributo
SALT LAKE CITY, Sept. 08, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (the "Company") today announced that its common stock has been suspended from trading on The Nasdaq Stock Market due to its voluntary filing for relief under Chapter 11 of the United States Bankruptcy Code on August 30, 2022 and the Company's inability to remain compliant with the listing requirements of The Nasdaq Stock Market. As previously disclosed, the Company does not intend to appeal the suspension and anticipated delisting of its stock from The Nasdaq Stock Market. Effective September 8, 2022, the Company's common stock is expected to begin trading on the OTC Market under the trading symbol "NBEVQ." Investors can find
SALT LAKE CITY, Sept. 02, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV) (the "Company") today announced that the U.S. Bankruptcy Court for the District of Delaware has granted the Company interim approval for first day motions related to its Chapter 11 restructuring. The approved motions will support the Company's ongoing operations during its financial restructuring process. The Court granted the Company access to a debtor-in-possession ("DIP") financing facility of $16 million provided by DIP Financing, LLC, which combined with the Company's projected revenues, will support its operations during the Chapter 11 process. The Court has also authorized the Company to continue paying
Gainers IMARA Inc. (NASDAQ:IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront. Azure Power Global Limited (NYSE:AZRE) shares jumped 35.4% to close at $4.86. Azure Power Global recently announced the resignation of Harsh Shah as CEO. SelectQuote, Inc. (NYSE:SLQT) rose 28.8% to close at $1.43. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 27.7% to close at $36.40 amid post-IPO volatility. Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 26.6% to close at $1.43. Spero Therapeutics shar
Newage Inc (NASDAQ:NBEV) shares are trading lower by 22.56% to $0.09 on continued weakness after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code. What Else? NewAge says the company has determined that the Chapter 11 process is the most expeditious way to pursue a strategic transaction and protect and preserve value for all stakeholders. NewAge says the company, with the help of its advisors, has secured a commitment for a "debtor in possession" financing facility of $16.0 million, subject to court approval. NewAge says this capital, together with revenue generated from ongoing operations, will provide liquidity
SALT LAKE CITY, July 08, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV) (the "Company" or "NewAge"), today announced that Kevin Manion, Chief Financial Officer, departed the Company as of July 1, 2022. Lawrence Perkins, who along with his firm SierraConstellation Partners LLC have been engaged to provide Chief Restructuring Officer (CRO) and other services to the Company, will assume the role of the Company's principal financial officer on an interim basis. "On behalf of NewAge, I want to thank Kevin for his contributions to our team. Kevin joined us in the middle of a major integration, and he resolved many operating issues for us. We wish him all the best," said Ed Brennan, NewAge'
SALT LAKE CITY, March 03, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), a direct selling company with a primary focus on healthy products, today announced the appointment of Michele Crocker to its Board of Directors. "I am delighted to welcome Michele to our Board of Directors," said Ed Brennan, Chairman of NewAge's Board. "Her strong background in the direct selling industry and her expertise in implementing programs that significantly improve recruitment, retailing and retention, will complement our existing Board and provide important insights into developing our most valuable asset – our Brand Partners." Ms. Crocker is Chief Operating Officer at CIENCE, a data company offering
DENVER, Dec. 01, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, announced today the appointment of Judith Hammerschmidt to its Board of Directors. "Judy has an impressive background having spent many years as outside counsel and as a board member helping companies expand in highly regulated industries," said Brent Willis, NewAge's Chief Executive Officer. "We enthusiastically welcome Judy to our Board and look forward to drawing upon her broad experience as we continue our growth and expansion for the benefit of our many stakeholders." Ms. Hammerschmidt has more than three decades of experience in cor
Roth Capital reiterated coverage of NewAge with a rating of Buy and set a new price target of $6.00 from $6.50 previously